Bessemer Group’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$281K Sell
11,230
-27,500
-71% -$775K ﹤0.01% 1312
2025
Q4
$1.22M Buy
38,730
+13,800
+55% +$458K ﹤0.01% 915
2025
Q3
$890K Buy
24,930
+6,595
+36% +$301K ﹤0.01% 686
2025
Q2
$1.06M Buy
18,335
+7,435
+68% +$420K ﹤0.01% 629
2025
Q1
$635K Buy
10,900
+3,665
+51% +$250K ﹤0.01% 815
2024
Q4
$583K Sell
7,235
-2,570
-26% -$220K ﹤0.01% 856
2024
Q3
$786K Sell
9,805
-7,900
-45% -$561K ﹤0.01% 821
2024
Q2
$1.08M Sell
17,705
-3,320
-16% -$197K ﹤0.01% 648
2024
Q1
$1.04M Buy
21,025
+150
+0.7% +$7.14K ﹤0.01% 671
2023
Q4
$874K Buy
20,875
+5,160
+33% +$176K ﹤0.01% 687
2023
Q3
$516K Buy
+15,715
New +$536K ﹤0.01% 785

Other funds holding PRCT